The impact of gut toxins on brain health in chronic kidney disease
Gut-Derived Toxins and Brain Microbleeds in Chronic Kidney Disease
This study is looking at how harmful substances made by gut bacteria in people with chronic kidney disease might impact brain health, particularly causing tiny bleeding in the brain, and it aims to help us understand how these substances can lead to inflammation and damage in the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10740882 on NIH RePORTER |
What this research studies
This research investigates how toxins produced by gut bacteria in patients with chronic kidney disease (CKD) may affect brain health, specifically leading to brain microbleeds. By examining the relationship between gut-derived uremic toxins and their effects on the brain, the study aims to understand how these toxins contribute to inflammation and damage to the blood-brain barrier. The research involves using animal models to manipulate levels of these toxins and observe the resulting effects on brain microbleeds and cognitive function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease who may be experiencing cognitive issues or are at risk for cerebrovascular diseases.
Not a fit: Patients without chronic kidney disease or those who do not have any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing brain damage and cognitive decline in patients with chronic kidney disease.
How similar studies have performed: Previous studies have shown associations between gut-derived toxins and cardiovascular issues, suggesting that this research could build on established findings, although the specific focus on brain microbleeds in CKD is relatively novel.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Lau, Wei Ling — University of California-Irvine
- Study coordinator: Lau, Wei Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.